Skip to main navigation
Skip to search
Skip to main content
Sort by
Biochemistry, Genetics and Molecular Biology
Cancer Cell
100%
DNA Methyltransferase
100%
Mesenchymal-Epithelial Transition
75%
IC50
50%
Osteoblast
50%
Gene Expression
50%
Promoter Region
50%
Myeloid
50%
Antiproliferative Activity
50%
Gelatinase A
50%
MMP2
50%
Azacitidine
50%
Cadherin
50%
Transcription
25%
Epigenetics
25%
Colon
25%
Hydrolase
25%
Embryogenesis
25%
Enzymatic Activity
25%
Enzyme
25%
Ubiquitin C
25%
Cell Proliferation
25%
Cellular Differentiation
25%
Cell Growth
25%
Cytotoxicity
25%
Matrix Metalloproteinase
25%
Cell Death
25%
Decitabine
25%
C-Terminus
25%
Drug Megadose
25%
Luciferase
25%
Green Fluorescent Protein
25%
Nucleoside
25%
Cytomegalovirus
25%
Messenger RNA
25%
Programmed Cell Death
25%
Enzyme Inhibition
25%
Pharmacology, Toxicology and Pharmaceutical Science
Malignant Neoplasm
100%
Osteosarcoma
100%
DNA Methyltransferase
75%
Antiproliferative Activity
50%
IC50
50%
Acute Myeloid Leukemia
50%
Gelatinase A
50%
Azacitidine
50%
Uvomorulin
50%
DNA Methyltransferase 3A
50%
Breast Cancer
25%
Prostate Cancer
25%
Matrix Metalloproteinase
25%
Decitabine
25%
Necrosis
25%
Colon Carcinoma
25%
Luciferase
25%
Nucleoside
25%
Enhanced Green Fluorescent Protein
25%
Myelodysplastic Syndrome
25%
Cytotoxicity
25%
Messenger RNA
25%
Enzyme Inhibition
25%
Burkitt's Lymphoma
25%
DNA Methyltransferase Inhibitor
25%
Cytomegalovirus
25%
Hydrolase
25%
Ubiquitin C
25%
Immunology and Microbiology
Cancer Cell
100%
Epithelial Mesenchymal Transition
75%
Promoter Region
50%
Myeloid
50%
Gene Expression
50%
Antiproliferative Activity
50%
IC50
50%
Cadherin
50%
Osteoblast
50%
Osteosarcoma Cell
50%
Cell Death
25%
Colon
25%
Cytotoxicity
25%
Cell Proliferation
25%
Cell Differentiation
25%
Cell Line
25%
Cytomegalovirus
25%
Cell Growth
25%
Embryo Development
25%
Carboxy Terminal Sequence
25%
Drug Megadose
25%
Prostate
25%
Ubiquitins
25%
Programmed Cell Death
25%
Enzyme Inhibition
25%
Osteosarcoma Cell Line
25%
Keyphrases
Primary Osteosarcoma
66%
Osteoblast Differentiation
66%
Osteosarcoma Cells
66%
Enhanced Catalytic Activity
33%
Saos-2
33%
Osteosarcoma Cell Lines
33%
Luciferase Reporter System
33%
HCT116 Colon Cancer Cells
33%
PC-3 Cell Line
33%